Citations

Showing 10 of 108162 citations.

Current approaches to management of high‐risk multiple myeloma
Goldman‐Mazur, Sarah , Kumar, Shaji , Kumar, Shaji K

Mayo Clinic

American Journal of Hematology | March 16, 2021 | Volume: 96 | Issue: 7 | Pages: 854-871

10.1002/ajh.26161 | PMID 33725367 Get It

AbstractThe median overall survival in multiple myeloma is rapidly approaching 10 years; however, in nearly a fifth of patients the prognosis remains poor. Therefore, the modern‐day management of myeloma patients should be individualized, with a more intense and continuous approach in these high‐risk patients. This includes first‐line treatment based on multi‐drug combinations employing the most effective drug combinations, upfront autologous stem cell transplantation (in eligible patients with tandem transplantation being a consideration), and maintenance based on proteasome inhibitor‐based combinations. This paper reviews the results of recent retrospective analyses and clinical trials, but also gives a glance into the future by presenting the ongoing trials.
Delayed Cutaneous Fluid Leakage after Fluoroscopic-Guided Epidural Steroid Injection
D’Souza, Ryan S. , Woods, Charonn D., Lee, Dae-Woong , Bendel, Markus A. , Lee, Daewoong, Bendel, Markus, D'Souza, Ryan S , Lee, Daewoong, Kissoon, Narayan

Mayo Clinic

Pain Medicine | March 16, 2021 | Volume: 22 | Issue: 12 | Pages: 3092-3095

10.1093/pm/pnab108 | PMID 33755154 Get It

Antibody Dynamics, Seroreversion, and Persistence After Severe Acute Respiratory Syndrome Coronavirus 2: Another Answer
Poland, Gregory A.

Mayo Clinic

Clinical Infectious Diseases | March 16, 2021 | Volume: 73 | Issue: 12 | Pages: 2163-2165

10.1093/cid/ciab243 | PMID 33730754 Get It

Super-resolution ultrasound localization microscopy based on a high frame-rate clinical ultrasound scanner: an in-human feasibility study
Huang, Chengwu , Zhang, Wei , Lok, U-Wai, Tang, Shanshan, Yin, Tinghui, Zhang, Xirui , Zhu, Lei, Sang, Maodong, Song, Pengfei, Zheng, Rongqin, Chen, Shigao, Chen, Shigao , Lok, U‐Wai , Yin, Tinghui , Gong, Ping , Zhang, Xirui , Huang, Chengwu , Lok, U-Wai , Zhang, Wei , Tang, Shanshan, Yin, Tinghui, Zhu, Lei, Sang, Maodong, Song, Pengfei, Zheng, Rongqin, Chen, Shigao

Mayo Clinic

Physics in Medicine & Biology | March 16, 2021 | Volume: 66 | Issue: 8 | Pages: 08NT01

10.1088/1361-6560/abef45 | PMID 33725687 Get It

Abstract Non-invasive detection of microvascular alterations in deep tissues in vivo provides critical information for clinical diagnosis and evaluation of a broad-spectrum of pathologies. Recently, the emergence of super-resolution ultrasound localization microscopy (ULM) offers new possibilities for clinical imaging of microvasculature at capillary level. Currently, the clinical utility of ULM on clinical ultrasound scanners is hindered by the technical limitations, such as long data acquisition time, high microbubble (MB) concentration, and compromised tracking performance associated with low imaging frame-rate. Here we present a robust in-human ULM on a high frame-rate (HFR) clinical ultrasound scanner to achieve super-resolution microvessel imaging using a short acquisition time (<10 s). Ultrasound MB data were acquired from different human tissues, including a healthy liver and a diseased liver with acute-on-chronic liver failure, a kidney, a pancreatic tumor, and a breast mass using an HFR clinical scanner. By leveraging the HFR and advanced processing techniques including sub-pixel motion registration, MB signal separation, and Kalman filter-based tracking, MBs can be robustly localized and tracked for ULM under the circumstances of relatively high MB concentration associated with standard clinical MB administration and limited data acquisition time in humans. Subtle morphological and hemodynamic information in microvasculature were shown based on data acquired with single breath-hold and free-hand scanning. Compared with contrast-enhanced power Doppler generated based on the same MB dataset, ULM showed a 5.7-fold resolution improvement in a vessel based on a linear transducer, and provided a wide-range blood flow speed measurement that is Doppler angle-independent. Microvasculatures with complex hemodynamics can be well-differentiated at super-resolution in both normal and pathological tissues. This preliminary study implemented the ultrafast in-human ULM in various human tissues based on a clinical scanner that supports HFR imaging, indicating the potentials of the technique for various clinical applications. However, rigorous validation of the technique in imaging human microvasculature (especially for those tiny vessel structure), preferably with a gold standard, is still required.
Commentary on: A New Target for Temple Volumization? An Anatomical and Ultrasound-Guided Study of the Intermediate Temporal Fat Pad
Cotofana, Sebastian , Cotofana, Sebastian

Mayo Clinic

Aesthetic Surgery Journal | March 16, 2021 | Volume: 41 | Issue: 12 | Pages: 1344-1345

10.1093/asj/sjab022 | PMID 33724338 Get It

From Tissue to Human Regeneration: The Development of a Comprehensive Regenerative Care Clinic for People With Diabetes
Hargraves, Ian , Behfar, Atta , Simha, Vinaya , Donoghue, Chenoa, Renner, Amy Seegmiller , Brito, Juan P. , Hargraves, Ian G, Behfar, Atta , Brito, Juan P , Montori, Víctor M.

Mayo Clinic

Regenerative Medicine | March 16, 2021 | Volume: 16 | Issue: 3 | Pages: 219-228

10.2217/rme-2020-0176 | PMID 33724876 Get It

Novel Genetic Variant Predicts Surgical Recurrence Risk in Crohn’s Disease Patients
Wang, Ming‐Hsi , Friton, Jessica, Raffals, Laura E. , Leighton, Jonathan A. , Pasha, Shabana F., Picco, Michael F., Monroe, Kelly, Nix, Billy D., Newberry, Rodney D. , Faubion, William A. , Friton, Jessica J, Newberry, Rodney D

Mayo Clinic

Inflammatory Bowel Diseases | March 16, 2021 | Volume: 27 | Issue: 12 | Pages: 1968-1974

10.1093/ibd/izaa362 | PMID 33724339 Get It

Abstract Background We aimed to identify a model of clinical and genetic risk factors through hypothesis-free search across genome that can predict the surgical recurrence risk after the first abdominal surgery in CD patients. Materials and Methods Two independent inflammatory bowel disease (IBD) cohort studies were used to derive and validate the genetic risk profile. The study subjects were genotyped using Illumina Immunochip custom genotyping array. Surgical recurrence was defined as having the second or more abdominal bowel resections after the first abdominal surgery at the time of study enrollment; nonsurgical recurrence was defined as having no further abdominal resection after the first abdominal surgery. Results Among 372 CD patients who had at least 1 abdominal surgery at the study enrollment, 132 (35.5%) had subsequent surgical recurrence after their first abdominal surgery, and 240 (64.5%) required no subsequent abdominal surgery at the end of follow up. Among clinical factors, multivariable analysis showed that history of immunomodulatory use (odds ratio [OR], 3.96; P = 0.002) and early era of CD first surgery (OR, 1.12; P = 1.01E-04) remained significant. Genotypic association tests identified a genome-wide significant locus rs2060886 in TCF4 at chr18q21.2 associated with surgical recurrence risk (OR, dom, 4.10 [2.37–7.11]; P = 4.58E-08). Conclusions Novel genetic locus rs2060886 in TCF4 was associated with surgical recurrence risk at genome-wide significance level among CD patients after their first abdominal surgery. Early era of CD first intestinal surgery predicts higher surgical recurrence risk. These results suggest that genetic variants may help guide the CD management strategy in patients at the highest risk of repeated abdominal surgeries.
Improved Prediction of Imminent Progression to Clinically Significant Memory Decline Using Surface Multivariate Morphometry Statistics and Sparse Coding
Stonnington, Cynthia M. , Initiative, for the Alzheimer’s Disease Neuroimaging, Wu, Jianfeng , Bauer, Robert, Devadas, Vivek, Reiman, Eric M. , Caselli, Richard J. , Locke, Dona E.C. , Initiative, for the Alzheimer’s Disease Neuroimaging, Zhang, Jie , Shi, Jie , Su, Yi , Chen, Kewei , Wang, Yalin

Mayo Clinic

Journal of Alzheimer's Disease | March 16, 2021 | Volume: 81 | Issue: 1 | Pages: 209-220

10.3233/jad-200821 | PMID 33749642 Get It

Background: Besides their other roles, brain imaging and other biomarkers of Alzheimer’s disease (AD) have the potential to inform a cognitively unimpaired (CU) person’s likelihood of progression to mild cognitive impairment (MCI) and benefit subject selection when evaluating promising prevention therapies. We previously described that among baseline FDG-PET and MRI measures known to be preferentially affected in the preclinical and clinical stages of AD, hippocampal volume was the best predictor of incident MCI within 2 years (79%sensitivity/78%specificity), using standard automated MRI volumetric algorithmic programs, binary logistic regression, and leave-one-out procedures. Objective: To improve the same prediction by using different hippocampal features and machine learning methods, cross-validated via two independent and prospective cohorts (Arizona and ADNI). Methods: Patch-based sparse coding algorithms were applied to hippocampal surface features of baseline TI-MRIs from 78 CU adults who subsequently progressed to amnestic MCI in approximately 2 years (“progressors”) and 80 matched adults who remained CU for at least 4 years (“nonprogressors”). Nonprogressors and progressors were matched for age, sex, education, and apolipoprotein E4 allele dose. We did not include amyloid or tau biomarkers in defining MCI. Results: We achieved 92%prediction accuracy in the Arizona cohort, 92%prediction accuracy in the ADNI cohort, and 90%prediction accuracy when combining the two demographically distinct cohorts, as compared to 79%(Arizona) and 72%(ADNI) prediction accuracy using hippocampal volume. Conclusion: Surface multivariate morphometry and sparse coding, applied to individual MRIs, may accurately predict imminent progression to MCI even in the absence of other AD biomarkers.
Activity of Lysin CF-296 Alone and in Addition to Daptomycin in a Rat Model of Experimental Methicillin-Resistant Staphylococcus aureus Osteomyelitis
Karau, Melissa J. , Schmidt-Malan, Suzannah M., Mandrekar, Jay , Lehoux, Dario , Schuch, Raymond , Cassino, Cara, Patel, Robin , Patel, Robin , Schuch, Raymond

Mayo Clinic

Antimicrobial Agents and Chemotherapy | March 16, 2021 | Volume: 65 | Issue: 6 | Pages: No page available

10.1128/aac.00117-21 | PMID 33722889 Get It

Phenotypic and Genomic Profiling of Staphylococcus argenteus in Canada and the United States and Recommendations for Clinical Result Reporting
Bommersbach, Carl E., Zittermann, Sandra , Burnham, Carey‐Ann D. , Patel, Robin , Schuetz, Audrey N. , Patel, Samir N. , Kus, Julianne V. , Bommersbach, Carl, Burnham, C A , Patel, Robin , Schuetz, Audrey N , Kus, Julianne V , Eshaghi, Alireza

Mayo Clinic

Journal of Clinical Microbiology | March 16, 2021 | Volume: 59 | Issue: 6 | Pages: No page available

10.1128/jcm.02470-20 | PMID 33731414 Get It

Staphylococcus argenteus is a newly described species, formerly known as S. aureus clonal complex 75 (CC75). Here, we describe the largest collection of S. argenteus isolates in North America, highlighting identification challenges.